Skip to content

An observational study on the risk of sleep apnea in patients with rheumatic diseases initially treated with glucocorticoids

An observational study on the risk of sleep apnea in patients with rheumatic diseases initially treated with glucocorticoids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065984
Enrollment
Unknown
Registered
2022-11-21
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea and rheumatic diseases

Interventions

OSA:No intervention: Patients with OSA based on sleep study

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Vital signs are stable, oxygen therapy can be temporarily stopped to complete sleep monitoring; 2. The diagnosis of rheumatic diseasesis is confirmed and the expert group decide to start glucocorticoids therapy; 3. Medical and human resources are available at that time.

Exclusion criteria

Exclusion criteria: 1. Hypoxia is too severe to stop oxygen therapy and unable to complete sleep monitoring; 2. Advanced stage of severe medical disease with limited survival time; 3. Significant psycho-neurological abnormalities and difficult to follow up; 4. Previously diagnosed OSA and be treated with CPAP; 5. Diagnosed with atrial fibrillation and have pacemaker implantation which is difficult to detect blood pressure and heart rate; 6. Previously recieved glucocorticoids therapy; 7. Medical history of tumor.

Design outcomes

Primary

MeasureTime frame
inflammatory markers;Fat distribution of total body and upper airway;Activity of rheumatic diseases;Change of sleep structure;

Secondary

MeasureTime frame
Cardiovascular events;Cerebrovascular events;New-onset diabetes;

Countries

China

Contacts

Public ContactJiang Xie

Beijing Anzhen Hospital, Capital Medical University

frank782008@aliyun.com+86 01064456527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026